BioNTech (United States)

BioNTech (United States)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (United States), United States, covering academic research published from 2003 to 2024. Read More.


Open Access Percentage

70%


Total
Publications

120


Total Open
Publications

84


Total
Citations

4.1K


Open Access
Percentage

70%


Total
Publications

120


Total Open
Publications

84


Total
Citations

4.1K

Wikipedia

Website

download

Breakdown

23% 27% 20% 30%

Publisher Open

23%

Both

27%

Other Platform Open

20%

Closed

30%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224262830Total Publications
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

22%OA Journal

OA Journal 22%

13

Hybrid 51%

31

No Guarantees 27%

16

Other Platform Open

Preprint 50%

28

Domain 46%

26

Other Internet 21%

12

Public 9%

5

Institution 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
26
DOI
Other Internet
14
bioRxiv
Preprint
12
Figshare
Public
7
Europe PMC
Domain
7
medRxiv
Preprint
6
Research Square
Preprint
4
ChemRxiv
Preprint
4
Unknown Repository
Other Internet
1
Preprints
Preprint
1
1 / 2

Data updated 7 April 2025

Share

Share

Share